Michael Saliba advises issuers, underwriters, sponsors, and investors on a range of complex domestic and cross-border capital markets transactions.
Drawing on his broad transactional experience and sector-specific knowledge, Mr. Saliba helps clients successfully navigate a range of capital markets transactions, including:
Acquisition financings
High-yield and investment grade debt offerings
Debt exchange offers, tender offers, and consent solicitations
Initial public offerings and deSPAC transactions
Project financings
Registered and private equity financings
Restructuring transactions
Spin-off transactions
Mr. Saliba also regularly counsels clients on a variety of corporate and securities law matters as well as high yield debt covenant and debt structuring analyses.
Experience
Mr. Saliba’s experience includes advising:
Debt Offerings
Aircastle Limited in multiple offerings of senior notes and in its inaugural preferred stock offering*
HC2 in its US$330 million high yield offering of senior secured notes*
Jefferies in the US$400 million high yield offering of senior secured notes by StoneMor*
NCR in multiple high yield offerings of senior notes*
R.R. Donnelley & Sons in its US$400 million high yield offering of senior secured notes*
Stryker in its €2.4 billion offering of senior notes*
Initial Public Offerings and deSPAC Transactions
Fortress Investment Group in the initial public offering of Brightline Holdings*
NextGen Acquisition Corporation in its merger with Xos*
Liability Management Transactions
Baxter International in its debt-for-equity exchanges and equity-for-equity exchange offer in connection with its spin-off of Baxalta*
Restructurings
ADVANZ Pharma in its restructuring and recapitalization transactions*
Highbridge Capital Management in the restructuring and refinancing transactions by Pernix Therapeutics*
iPayment Holdings and iPayment in their units and US$400 million senior notes offerings and later restructuring*
Firm represents the lenders in a financing to support the sale to an investor group led by Stone Point Capital and Clayton, Dubilier & Rice, valuing Truist Insurance Holdings at US$15.5 billion.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
